Cutaneous Squamous Cell Carcinoma Pipeline Insights 2024 “Cutaneous Squamous Cell Carcinoma Pipeline Insight, 2024” report by DelveInsight...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - MOUNTAINTODAY.IN - A La Une - 17/Jun 18:16
Essential Tremor Pipeline Analysis 2024 | Clinical Trials, Latest Approvals, Treatment Outlook, Therapies, Key Companies | Merz Pharma, SAGE Therapeutics, GE Healthcare, Praxis Precision Medicines, OB
Essential Tremor Pipeline Analysis 2024 “Essential Tremor Pipeline Insight, 2024” report by DelveInsight outlines a comprehensive assessment of the present clinical/non-clinical development activities and growth prospects across the Essential Tremor
Articles similaires
Methicillin-resistant Staphylococcus Aureus Infections Pipeline Insights | Clinical Trials, Latest Approvals, Therapies, Key Players | Pfizer, Forest Laboratories, AstraZeneca, Cumberland Pharma
mountaintoday.in - 19/Jun 07:16
Methicillin-resistant Staphylococcus Aureus Infections Pipeline Insights “Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Pipeline...
Polycystic Ovarian Syndrome Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Sanofi, Novartis, Teva Pharma, Addex Therapeutics
mountaintoday.in - 20/Jun 09:56
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Polycystic Ovarian Syndrome pipeline constitutes 4+ key companies...
Obesity Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Merck, Alizyme, Bayer, GlaxoSmithKline, Bristol-Myers Squibb, Currax Pharma
mountaintoday.in - 19/Jun 10:44
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Obesity pipeline constitutes 100+ key companies continuously working...
Hyperuricemia Pipeline Assessment, 2024 Updates | In-depth Insights into the Emerging Drugs, Latest Drug Approvals, Clinical Trials, and Treatment Outlook | Hikma Pharma, Novartis, Pfizer, Roche
mountaintoday.in - 19/Jun 10:56
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hyperuricemia pipeline constitutes 12+ key companies continuously...
Crohn’s Disease Pipeline Outlook 2024: FDA, EMA, PDMA Approvals, Therapies, Clinical Trials, Treatment Market, Mechanism of Action, ROA and Companies by DelveInsight
mountaintoday.in - 19/Jun 07:04
Crohn’s Disease Pipeline (New York, United States) As per DelveInsight’s assessment, globally, Crohn’s Disease pipeline constitutes 70+ key...
Glioblastoma Multiforme Pipeline Insights 2024 | Clinical Trials, Latest Approvals, Treatment Outlook, Therapies, Companies | Genentech, Merck, Daiichi Sankyo, VBL Therapeutics, Diffusion Pharma
mountaintoday.in - 19/Jun 07:44
Glioblastoma Multiforme Pipeline Insights 2024 As per DelveInsight’s assessment, about 100+ key pharma and biotech companies are working on 100+...
Dravet Syndrome Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies | GW Pharma, Zogenix Inc, Stoke Therapeutics, Takeda Pharma, Supernus Pharma
mountaintoday.in - 20/Jun 10:32
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Dravet Syndrome pipeline constitutes 12+ key companies continuously...
STAT Inhibitors Pipeline Outlook 2024: Clinical Trials, FDA, EMA, PMDA Approvals, Therapies, Growth Opportunities, and Companies by DelveInsight
mountaintoday.in - 19/Jun 07:12
STAT Inhibitors Pipeline STAT Inhibitors Pipeline report provides comprehensive insights about 60+ companies and 60+ pipeline drugs based on STAT...
Endometrial Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight
mountaintoday.in - 21/Jun 19:16
DelveInsight’s, “Endometrial Cancer Pipeline Insight 2024” report provides comprehensive insights about 50+ companies...
Les derniers communiqués
-
Aucun élément